HK1186671A1 - Formulations for the treatment of disorders of the upper respiratory tract - Google Patents

Formulations for the treatment of disorders of the upper respiratory tract

Info

Publication number
HK1186671A1
HK1186671A1 HK13114210A HK13114210A HK1186671A1 HK 1186671 A1 HK1186671 A1 HK 1186671A1 HK 13114210 A HK13114210 A HK 13114210A HK 13114210 A HK13114210 A HK 13114210A HK 1186671 A1 HK1186671 A1 HK 1186671A1
Authority
HK
Hong Kong
Prior art keywords
disorders
formulations
treatment
respiratory tract
upper respiratory
Prior art date
Application number
HK13114210A
Other languages
English (en)
Chinese (zh)
Inventor
Ezio Bombardelli
Massimo Ronchi
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1186671A1 publication Critical patent/HK1186671A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK13114210A 2010-10-11 2013-12-23 Formulations for the treatment of disorders of the upper respiratory tract HK1186671A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A001852A IT1402018B1 (it) 2010-10-11 2010-10-11 Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
PCT/EP2011/067357 WO2012049045A1 (fr) 2010-10-11 2011-10-05 Formulations pour traitement de troubles des voies respiratoires supérieures

Publications (1)

Publication Number Publication Date
HK1186671A1 true HK1186671A1 (en) 2014-03-21

Family

ID=43737984

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13114210A HK1186671A1 (en) 2010-10-11 2013-12-23 Formulations for the treatment of disorders of the upper respiratory tract

Country Status (21)

Country Link
US (1) US9168276B2 (fr)
EP (1) EP2627345B1 (fr)
JP (2) JP6250397B2 (fr)
KR (1) KR101870979B1 (fr)
CN (1) CN103189065B (fr)
AR (1) AR083366A1 (fr)
AU (1) AU2011315708B2 (fr)
BR (1) BR112013008771B1 (fr)
CA (1) CA2814312C (fr)
DK (1) DK2627345T3 (fr)
ES (1) ES2496892T3 (fr)
HK (1) HK1186671A1 (fr)
IL (1) IL225668A (fr)
IT (1) IT1402018B1 (fr)
MX (1) MX342986B (fr)
PL (1) PL2627345T3 (fr)
PT (1) PT2627345E (fr)
RU (1) RU2580643C2 (fr)
SG (1) SG189345A1 (fr)
SI (1) SI2627345T1 (fr)
WO (1) WO2012049045A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6075526B2 (ja) * 2012-07-04 2017-02-08 アサヒビール株式会社 ビール又はビール様飲料及びその製造方法
EP2908834B1 (fr) * 2012-10-17 2017-07-12 Montero Gida Sanayi Ve Ticaret A.S. Nouvelles formulations comprenant des extraits de plantes
CN104304548A (zh) * 2014-10-27 2015-01-28 陈国勇 一种预防感冒茶及其制备方法
EP3103465A1 (fr) 2015-06-10 2016-12-14 Raman Mehta Formulations pour le traitement de lésions de muqueuses
EP3103464A1 (fr) 2015-06-10 2016-12-14 Raman Mehta Formulations pour le traitement de troubles de la bouche, la gorge et des voies respiratoires
JP2018528977A (ja) 2015-09-22 2018-10-04 バイタリティ バイオファーマ インコーポレイテッドＶｉｔａｌｉｔｙ Ｂｉｏｐｈａｒｍａ， Ｉｎｃ． カンナビノイドグリコシドプロドラッグおよび合成の方法
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
EP3634390B1 (fr) * 2017-05-09 2023-09-27 Graphium Biosciences, Inc. Compositions antimicrobiennes comprenant du cbd ou du thc contre l'infection a c. difficile ou a e. faecalis
EP3946404A1 (fr) * 2019-03-29 2022-02-09 Evonik Operations GmbH Préparations contenant des extraits de baies destinées à être utilisées dans la prophylaxie et/ou le traitement d'infections virales provoquées par des paramyxovirus
WO2020201055A1 (fr) * 2019-03-29 2020-10-08 Evonik Operations Gmbh Préparations contenant des extraits de baies destinées à être utilisées dans la prophylaxie et/ou le traitement d'infections virales provoquées par des pneumoviridae
AU2020252112A1 (en) * 2019-03-29 2021-11-25 Evonik Operations Gmbh Combined preparation comprising an anthocyanin composition and an antiviral agent
KR102232733B1 (ko) * 2019-04-16 2021-03-26 주식회사 파미니티 에키네시아 추출물을 포함하는 항바이러스용 조성물
IT201900024997A1 (it) * 2019-12-20 2021-06-20 Dymalife Res S R L Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie
IT202000018949A1 (it) 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106972B2 (ja) * 1987-04-24 1995-11-15 佐藤製薬株式会社 歯科口腔用薬剤
EP1049480B1 (fr) * 1998-01-30 2002-09-11 Rhinopharma AS Agent antiviral d'origine vegetale
JP2000136141A (ja) * 1998-10-30 2000-05-16 Sumitomo Forestry Co Ltd 抗菌剤
US6241975B1 (en) * 1999-07-24 2001-06-05 Pacific Corporation Method for preparation of plant extract powder
JP2001122795A (ja) * 1999-10-27 2001-05-08 Nissui Pharm Co Ltd 感染性疾患予防・治療剤
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
CN1164299C (zh) * 2001-09-07 2004-09-01 张印昌 治疗急慢性炎症的中药制剂克炎口服液及制作方法
JP2003113013A (ja) * 2001-09-28 2003-04-18 Lion Corp 植物性抗菌防腐剤
JP4444593B2 (ja) * 2003-08-21 2010-03-31 日本メナード化粧品株式会社 抗菌剤
ITMI20032287A1 (it) 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US20080057143A1 (en) 2006-06-01 2008-03-06 Mohammad Madjid Method of using composition comprising pomegranate extracts against influenza
CN101057953A (zh) * 2006-04-21 2007-10-24 陈祖辉 对付病毒感染疾患的多靶协同防治制剂
WO2007133721A2 (fr) * 2006-05-12 2007-11-22 Interleukin Genetics, Inc. Compositions alimentaires et procédés de traitement de maladie parodontale
US7820207B2 (en) * 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions
US20090035226A1 (en) * 2007-07-31 2009-02-05 Phenolics, Llc Use of cranberry extract enriched in total phenols and free, essentially free, or substantially free of sugars, acids, sulfur and other contaminants, for periodontal treatment
US8496975B2 (en) 2008-04-24 2013-07-30 Indena S.P.A. Compositions for the treatment and prevention of infections of the oral cavity
US20090304826A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for dermatoses
ES2393239T3 (es) * 2008-06-05 2012-12-19 Indena S.P.A. Composiciones para el tratamiento de trastornos del tracto respiratorio superior y síndromes de infuenza

Also Published As

Publication number Publication date
ITMI20101852A1 (it) 2012-04-12
IT1402018B1 (it) 2013-08-28
IL225668A (en) 2016-12-29
IL225668A0 (en) 2013-06-27
CN103189065A (zh) 2013-07-03
CN103189065B (zh) 2015-03-18
CA2814312A1 (fr) 2012-04-19
WO2012049045A1 (fr) 2012-04-19
CA2814312C (fr) 2021-10-12
SG189345A1 (en) 2013-05-31
AU2011315708A1 (en) 2013-04-18
KR20130142115A (ko) 2013-12-27
DK2627345T3 (da) 2014-09-01
BR112013008771A2 (pt) 2021-04-20
ES2496892T3 (es) 2014-09-22
US20130280355A1 (en) 2013-10-24
BR112013008771B1 (pt) 2022-02-22
US9168276B2 (en) 2015-10-27
JP2016155878A (ja) 2016-09-01
AR083366A1 (es) 2013-02-21
PL2627345T3 (pl) 2015-01-30
EP2627345B1 (fr) 2014-07-23
JP2013539770A (ja) 2013-10-28
JP6250397B2 (ja) 2017-12-20
MX2013004008A (es) 2013-04-24
EP2627345A1 (fr) 2013-08-21
RU2013121576A (ru) 2014-11-20
SI2627345T1 (sl) 2014-10-30
AU2011315708B2 (en) 2014-03-20
KR101870979B1 (ko) 2018-06-25
RU2580643C2 (ru) 2016-04-10
PT2627345E (pt) 2014-09-04
MX342986B (es) 2016-10-19

Similar Documents

Publication Publication Date Title
HK1186671A1 (en) Formulations for the treatment of disorders of the upper respiratory tract
EP2557921A4 (fr) Méthodes de traitement de troubles de respiration liés au sommeil
ZA201205829B (en) Treatment of respiratory disorders
EP2552433A4 (fr) Compositions et procédés pour le traitement de troubles somatosensoriels
ZA201208535B (en) Formulations of quinones for the treatment of ophthalmic diseases
HK1184370A1 (zh) 用於治療疼痛的藥物組合
IL222890A0 (en) Medicaments for the treatment of il-1beta related conditions
HK1203390A1 (en) Polyinosinic-polycytidylic acid (poly(1:c)) formulations for the treatment of upper respiratory tract infections -((i:c))
IL225896A0 (en) Treatment of mecp-2 related disorders
GB201002243D0 (en) Respiratory disease treatment
ZA201305970B (en) Arylosulfonami for the treatment of cns diseases
GB201002224D0 (en) Respiratory disease treatment
GB201006167D0 (en) Compounds for the treatment of metabolic disorders
GB201006166D0 (en) Compounds for the treatment of metabolic disorders
ZA201207696B (en) Compound for treatment of respiratory condition or disease
EP2578206A4 (fr) Composition pharmaceutique pour traiter les affections de la partie inférieure du système urogénital
GB201001912D0 (en) Treatment of respiratory disorders
IL223055A0 (en) Compositions for the treatment of gynaecological disorders
GB201002235D0 (en) Respiratory disease treatment
GB2477540A8 (en) Respiratory disease treatment
GB201001903D0 (en) Respiratory disease treatment
GB201007205D0 (en) Treatment of joint disorders
GB201002841D0 (en) Treatment of inflammatory respiratory disease
GB201019482D0 (en) Compounds for the treatment of metabolic disorders
GB201006164D0 (en) Compounds for the treatment of metabolic disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231010